Immune Netw.  2009 Jun;9(3):84-89. 10.4110/in.2009.9.3.84.

CD137-CD137 Ligand Interactions in Inflammation

Affiliations
  • 1School of Biological Sciences, University of Ulsan, Ulsan, Korea. bkwon@ulsan.ac.kr

Abstract

The main stream of CD137 studies has been directed to the function of CD137 in CD8+ T-cell immunity, including its anti-tumor activity, and paradoxically the immunosuppressive activity of CD137, which proves to be of a great therapeutic potential for animal models of a variety of autoimmune and inflammatory diseases. Recent studies, however, add complexes to the biology of CD137. Accumulating is evidence supporting that there exists a bidirectional signal transduction pathway for the CD137 receptor and its ligand (CD137L). CD137/CD137L interactions are involved in the network of hematopoietic and nonhematopoietic cells in addition to the well characterized antigen-presenting cell-T cell interactions. Signaling through CD137L plays a critical role in the differentiation of myeloid cells and their cellular activities, suggesting that CD137L signals trigger and sustain inflammation. The overall consequence might be that the amplified inflammation by CD137L enhances the T-cell activity together with CD137 signals by upregulating costimulatory molecules, MHC molecules, cell adhesion molecules, cytokines, and chemokines. Solving this outstanding issue is urgent and will have an important clinical implication.

Keyword

CD137; CD137 ligand; inflammation

MeSH Terms

4-1BB Ligand
Biology
Cell Adhesion Molecules
Cell Communication
Chemokines
Cytokines
Inflammation
Models, Animal
Myeloid Cells
Rivers
Signal Transduction
T-Lymphocytes
4-1BB Ligand
Cell Adhesion Molecules
Chemokines
Cytokines

Figure

  • Figure 1 A schematic diagram showing a bidirectional signal transduction of the CD137 and CD137L pathway.


Cited by  4 articles

Recombinant TAT-CD137 Ligand Cytoplasmic Domain Fusion Protein Induces the Production of IL-6 and TNF-α in Peritoneal Macrophages
Jung Dae Kim, Eun Ah Lee, Nguyen N. Quang, Hong Rae Cho, Byungsuk Kwon
Immune Netw. 2011;11(4):216-222.    doi: 10.4110/in.2011.11.4.216.

Anti-CD137 mAb Deletes Both Donor CD4+ and CD8+ T Cells in Acute Graft-versus-host Disease
Juyang Kim, Hong Rae Cho, Byungsuk Kwon
Immune Netw. 2011;11(6):428-430.    doi: 10.4110/in.2011.11.6.428.

Regulation of Inflammation by Bidirectional Signaling through CD137 and Its Ligand
Byungsuk Kwon
Immune Netw. 2012;12(5):176-180.    doi: 10.4110/in.2012.12.5.176.

Integration of the Innate and Adaptive Immunity by CD137-CD137L Bidirectional Signals: Implications in Allograft Rejection
Sang June Park, Jong Soo Lee, Byungsuk Kwon, Hong Rae Cho
J Korean Soc Transplant. 2014;28(3):113-120.    doi: 10.4285/jkstn.2014.28.3.113.


Reference

1. Kwon B, Moon CH, Kang S, Seo SK, Kwon BS. 4-1BB: still in the midst of darkness. Mol Cells. 2000. 10:119–126.
Article
2. Kwon B, Lee HW, Kwon BS. New insights into the role of 4-1BB in immune responses: beyond CD8+ T cells. Trends Immunol. 2002. 23:378–380.
Article
3. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009. 9:271–285.
Article
4. Shuford WW, Klussman K, Tritchler DD, Loo DT, Chalupny J, Siadak AW, Brown TJ, Emswiler J, Raecho H, Larsen CP, Pearson TC, Ledbetter JA, Aruffo A, Mittler RS. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med. 1997. 186:47–55.
Article
5. Takahashi C, Mittler RS, Vella AT. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol. 1999. 162:5037–5040.
6. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collin M, Byrne MC. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002. 16:311–323.
7. Melero I, Shuford WW, Newby SA, Aruffo A, Ledbetter JA, Hellström KE, Mittler RS, Chen L. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med. 1997. 3:682–685.
Article
8. Sun Y, Lin X, Chen HM, Wu Q, Subudhi SK, Chen L, Fu YX. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol. 2002. 168:1457–1465.
Article
9. Sun Y, Chen HM, Subudhi SK, Chen J, Koka R, Chen L, Fu YX. Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat Med. 2002. 8:1405–1413.
Article
10. Foell J, Strahotin S, O'Neil SP, McCausland MM, Suwyn C, Haber M, Chander PN, Bapat AS, Yan XJ, Chiorazzi N, Hoffmann MK, Mittler RS. CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice. J Clin Invest. 2003. 111:1505–1518.
Article
11. Seo SK, Choi JH, Kim YH, Kang WJ, Park HY, Suh JH, Choi BK, Vinay DS, Kwon BS. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med. 2004. 10:1088–1094.
Article
12. Foell JL, Diez-Mendiondo BI, Diez OH, Holzer U, Ruck P, Bapat AS, Hoffmann MK, Mittler RS, Dannecker GE. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance. Immunology. 2004. 113:89–98.
Article
13. Kim J, Choi WS, La S, Suh J-H, Kim B-S, Cho HR, Kwon BS, Kwon B. Stimulation with 4-1BB inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells. Blood. 2005. 105:2206–2213.
Article
14. Kim J, Kim HJ, Park K, Kim J, Yagita H, Nam SK, Cho HR, Kwon B. Costimulatory molecule-targeted immunotherapy of chronic graft-versus-host disease. Blood. 2007. 110:776–782.
Article
15. Shao H, Fu Y, Liao T, Peng Y, Chen L, Kaplan HJ, Sun D. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells. Invest Ophthalmol Vis Sci. 2005. 46:596–603.
Article
16. Fukushima A, Yamaguchi T, Ishida W, Fukata K, Mittler RS, Yagita H, Ueno H. Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice. J Immunol. 2005. 175:4897–4903.
Article
17. Cho YS, Kwon B, Lee T-H, Moon K-A, La S, Lee J, Lee SD, Oh Y-M, Moon H-B. 4-1BB stimulation inhibits allergen specific IgE, airway hyperreactivity, and eosinophilic inflammation in asthmatic mice. Clin Exp Allergy. 2006. 36:377–385.
Article
18. Polte T, Foell J, Werner C, Hoymann HG, Braun A, Burdach S, Mittler RS, Hansen G. CD137-mediated immunotherapy for allergic asthma. J Clin Invest. 2006. 116:1025–1036.
Article
19. Sun Y, Blink SE, Liu W, Lee Y, Chen B, Solway J, Weinstock J, Chen L, Fu YX. Inhibition of Th2-mediated allergic airway inflammatory disease by CD137 costimulation. J Immunol. 2006. 177:814–821.
Article
20. Drenkard D, Becke FM, Langstein J, Spruss T, Kunz-Schughart LA, Tan TE, Lim YC, Schwarz H. CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J. 2007. 21:456–463.
Article
21. Olofsson PS, Soderstrom LA, Wagstater D, Sheikine Y, Ocaya P, Lang F, Rabu C, Chen L, Paulsson-Berne GP, Sirsjo A, Hansson GK. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation. 2008. 117:1292–1301.
Article
22. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat Immunol. 2002. 3:33–41.
Article
23. MacHugh RS. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002. 16:311–323.
24. Wilcox RA, TAmada K, Strome SE, Chen L. Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic activity. J Immunol. 2002. 169:4230–4236.
Article
25. Kim D-H, Chang W-S, Lee Y-S, Lee K-A, Kim Y-K, Kwon BS, Kang C-Y. 4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligand-induced airway hyperresponsiveness and inflammation. J Immunol. 2008. 180:2062–2068.
Article
26. Lee S-C, Ju S-A, Pack H-N, Heo S-K, Suh J-H, Park S-M, Choi B-K, Kwon BS, Kim BS. 4-1BB (CD137) is required for rapid clearance of Listeria monocytogens infection. Infect Immun. 2005. 73:5144–5151.
Article
27. Heinisch IVWM, Daigle I, Knopfli B, Simon H-W. CD137 activation abrogates granulocyte-macrophage colony-stimulating factor-mediated anti-apoptosis in neutrophils. Eur J Immunol. 2000. 30:3441–3446.
Article
28. Nishimoto H, Lee S-W, Hong H, Potter KG, Maeda-Yamaoto M, Kinoshita T, Kawakami Y, Mittler RS, Kwon BS, Ware CF, Croft M, Kawakami T. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood. 2005. 106:4241–4248.
Article
29. Heinisch IVWM, Bizer C, Volgger W, Simon H-W. Functional CD137 receptors are expressed by eosinophils form patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE mediated eosinophilic disorders. J Allergy Clin Immunol. 2001. 108:21–28.
Article
30. Haga T, Suzuki J-I, Kosuge H, Ogawa M, Saiki H, Haraguchi G, Maejima Y, Isobe M, Uede T. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway. J Mol Cell Cardiol. 2009. 46:719–727.
Article
31. Lee S-W, Park Y, So T, Kwon BS, Cheroutre H, Mittler RS, Croft M. Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat Immunol. 2008. 9:917–926.
Article
32. Saiki H, Suzuki J-I, Kosuge H, Hiraguchi G, Ishihara T, Haga T, Maejima Y, Isobe M, Uede T. Blockade of the 4-1BB pathway attenuates graft arterial disease in cardiac allografts. Int Heart J. 2008. 49:105–118.
Article
33. Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B. Gene that distinguishes physiological and pathological angiogenesis. Cancer Cell. 2007. 11:539–554.
Article
34. Seko Y, Takahashi N, Oshima H. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimultory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxackievirus B3. J Pathol. 2001. 195:593–603.
Article
35. Langstein J, Michel J, Fritsche J, Kreutz M, Andreesen R, Schwarz H. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling. J Immunol. 1998. 160:2488–2494.
36. Jiang D, Chen Y, Schwarz H. CD137 induces proliferation of murine hematopoietic progenitor cells and differentiation to macrophages. J Immunol. 2008. 181:3923–3932.
Article
37. Jiang D, Yue PS, Drenkard D, Schwarz H. Induction of proliferation and monocytic differentiation of human CD34+ cells by CD137 ligand signaling. Stem Cells. 2008. 26:2372–2381.
Article
38. Seo SK, Park HY, Choi JH, Kim WY, Kim YH, Jung HW, Kwon B, Lee HW, Kwon BS. Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J Immunol. 2003. 171:576–583.
Article
39. Wang J, Guo Z, Dong Y, Kim O, Hart J, Adams A, Larsen CP, Mittler RS, Newell KA. Role of 4-1BB in allograft rejection mediated by CD8+ T cells. Am J Transplant. 2003. 3:543–551.
Article
40. Cho HR, Kwon B, Yagita H, La S, Lee EA, Kim JE, Akiba H, Kim J, Suh JH, Vinay DS, Ju SA, Kim BS, Mittler RS, Okumura K, Kwon BS. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival. Transpl Int. 2004. 17:351–361.
Article
41. Cheung CTY, Deisher TA, Luo H, Yanagawa B, Bonigut S, Samra A, Zhao H, Walker EK, McManus BM. Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis. Lab Invest. 2007. 87:651–661.
Article
42. Kim W, Kim J, Jung D, Kim H, Cho H-J, Cho HR, Kwon B. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2009. 15:306–314.
Article
43. Lee SW, Vella AT, Kwon BS, Croft M. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J Immunol. 2005. 174:6803–6808.
Article
44. Vinay DS, Choi BK, Bae JS, Kim WY, Gebhardt BM, Kwon BS. CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses. J Immunol. 2004. 173:4218–4229.
Article
45. Sun M, Fink PJ. A new class of reverse signaling costimulators belongs to the TNF family. J Immunol. 2007. 179:4307–4312.
Article
46. Pauly S, Broll K, Witmann M, Giegerich G, Schwarz H. CD137 is expressed by follicular dendritic cells and costimulates B lymphocytes in germinal centers. J Leukocyte Biol. 2002. 72:35–42.
47. Schwarz H. Biological activities of reverse signal transduction through CD137 ligand. J Leukoc Biol. 2005. 77:281–286.
Article
48. Lippert U, Zachmann K, Ferrari DM, Schwarz H, Brunner E, Nahhub-ul Latif AHM, Neumann C, Soruri A. CD137 lignd reverse signaling has multiple functions in human dendritic cells during an adaptive immune response. Eur J Immunol. 2008. 38:1024–1032.
Article
49. Saito K, Ohara N, Hotokezaka H, Fukumoto F, Yuasa K, Naito M, Fujiwara T, Nakayama K. Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis. J Biol Chem. 2004. 279:13555–13563.
Article
50. Kim D-K, Lee SC, Lee HW. CD137 ligand-memdiated reverse signals increase viability and cytokine expression in murine myeloid cells: involvement of mTOR/p70S6 kinase and AKT. Eur J Immunol. (In press).
51. Kang YJ, Kim SO, Shhimada S, Otsuka M, Seit-Nebi A, Kwon BS, Watts TH, Han J. Cell surface 4-1BBL mediates sequential signaling pathways 'down-stream' of TLR and is required for sustained TNF production in macrophages. Nat Immunol. 2007. 8:601–609.
Article
Full Text Links
  • IN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr